Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes

• Benjamin J. M. Tallon,

  Affiliations Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada, Division of Experimental Medicine, McGill University, Montréal, Québec, Canada

  ⨯
• Julie Bruneau,

  Affiliations Centre de recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada, Family Medicine Department, Université de Montréal, Montréal, Québec, Canada

  ⨯
• Christos M. Tsoukas,

  Affiliations Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada, Division of Experimental Medicine, McGill University, Montréal, Québec, Canada, Division of Clinical Immunology and Allergy, McGill University Health Centre, Montréal, Québec, Canada

  ⨯
• Jean-Pierre Routy,

  Affiliations Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada, Immunodeficiency Service and Division of Hematology, Royal Victoria Hospital, McGill University Health Centre, Montréal, Québec, Canada

  ⨯
• Zahra Kiani,

  Affiliations Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada, Division of Experimental Medicine, McGill University, Montréal, Québec, Canada

  ⨯
• Xianming Tan,

  Affiliation Biostatistics Core Facility, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada

  ⨯
• Nicole F. Bernard

  * E-mail: nicole.bernard@mcgill.ca

  Affiliations Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada, Division of Experimental Medicine, McGill University, Montréal, Québec, Canada, Division of Clinical Immunology and Allergy, McGill University Health Centre, Montréal, Québec, Canada

  ⨯